Loading...
PROCEPT BioRobotics Corporation
PRCT•NASDAQ
Healthcare
Medical - Devices
$55.72
$-2.92(-4.98%)
PROCEPT BioRobotics Corporation (PRCT) Financial Performance & Income Statement Overview
Review PROCEPT BioRobotics Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
64.84%
↑ 64.84%
Operating Income Growth
11.50%
↑ 11.50%
Net Income Growth
13.68%
↑ 13.68%
Operating Cash Flow Growth
8.14%
↑ 8.14%
Operating Margin
-38.70%
↓ 38.70%
Gross Margin
62.20%
↑ 62.20%
Net Profit Margin
-36.20%
↓ 36.20%
ROE
-28.09%
↓ 28.09%
ROIC
-20.63%
↓ 20.63%
PROCEPT BioRobotics Corporation (PRCT) Income Statement & Financial Overview
Review PROCEPT BioRobotics Corporation's (PRCT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $68.24M | $58.37M | $53.35M | $44.54M |
| Cost of Revenue | $24.56M | $21.46M | $23.14M | $19.50M |
| Gross Profit | $43.67M | $36.91M | $30.21M | $25.03M |
| Gross Profit Ratio | $0.64 | $0.63 | $0.57 | $0.56 |
| R&D Expenses | $15.07M | $16.65M | $16.23M | $13.08M |
| SG&A Expenses | $48.32M | $42.69M | $40.81M | $39.60M |
| Operating Expenses | $63.38M | $59.34M | $57.04M | $52.68M |
| Total Costs & Expenses | $87.95M | $80.80M | $80.18M | $72.19M |
| Interest Income | $3.33M | $2.59M | $2.23M | $2.74M |
| Interest Expense | $969000.00 | $1.14M | $1.03M | $1.04M |
| Depreciation & Amortization | $1.45M | $1.33M | $1.27M | $1.18M |
| EBITDA | -$16.43M | -$18.51M | -$23.33M | -$23.73M |
| EBITDA Ratio | -$0.24 | -$0.32 | -$0.44 | -$0.53 |
| Operating Income | -$19.71M | -$22.43M | -$26.83M | -$27.65M |
| Operating Income Ratio | -$0.29 | -$0.38 | -$0.50 | -$0.62 |
| Other Income/Expenses (Net) | $854000.00 | $1.45M | $1.20M | $1.69M |
| Income Before Tax | -$18.86M | -$20.97M | -$25.63M | -$25.96M |
| Income Before Tax Ratio | -$0.28 | -$0.36 | -$0.48 | -$0.58 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $1.14M |
| Net Income | -$18.86M | -$20.97M | -$25.63M | -$25.96M |
| Net Income Ratio | -$0.28 | -$0.36 | -$0.48 | -$0.58 |
| EPS | -$0.36 | -$0.40 | -$0.50 | -$0.51 |
| Diluted EPS | -$0.36 | -$0.40 | -$0.50 | -$0.51 |
| Weighted Avg Shares Outstanding | $52.07M | $52.01M | $51.62M | $51.01M |
| Weighted Avg Shares Outstanding (Diluted) | $52.07M | $52.01M | $51.62M | $51.01M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan